Stirling Products Limited

ASX:STI ISIN:AU000000STI8

Feb 10, 2012

OVERVIEW | NEWS | MULTIMEDIA | RESEARCH

Stirling Products Limited Company Summary

Stirling Products is developing patented animal growth agents that increase meat production, therefore improving the production efficiency of livestock animals, while decreasing fat accumulation for the benefit of consumers. The Stirling growth agents are under development for swine, poultry, cattle and sheep for global markets and are being positioned to take a major role in reducing the global use of antibiotics and steroid hormones in livestock. Stirling is also developing veterinary medications for heaves in horses through its joint venture in Europe (Pulmovet ApS, www.pulmovet.com) and an obesity treatment in companion animals.

Stirling Products recently acquired a Canadian company Progressive BioActives Incorporated (PBI) under its North American subsidiary, Stirling Products NA Inc. PBI is part of the Bioscience cluster established on located Prince Edward Island, Canada. PBI's lead product ProVale, is the latest high purity beta glucan extract that has been designed as an alternative tool for sustainable livestock management in face of increasing viral disease challenges where antibiotics have no or limited application. ProVale is available for targeted applications in swine, poultry and farmed aquaculture with a future focus on further developing applications for companion animals (e.g. horses, dogs, cats and reptiles).

DIRECTORS / OFFICERS

Dr Calvin London B.Sc. (Hon.), M.Sc., Ph.D., ASM
Managing Director
Dr London has over twenty-five years international experience in the pharmaceutical, biological and biotechnology industry, specialising in technical development, regulatory and quality management at an executive level. He has expertise in the manufacturing requirements of complex pharmaceutical products (SVP, LVP and cytotoxic drug products), non-sterile prescription drugs, devices and diagnostics.

ANNUAL REPORT

COMPANY DATA

	Headquarters	Level 11, The BGC Centre

		28 The Esplanade

		PERTH WA 6000

		Australia

	Telephone	+61 8 9480 1480

	Fax	+61 8 9226 4144

	Principal Sector	Health & Pharm

	Principal Industry	Biotechnology

	Listed	1997/07/24

	Homepage	www.stirlingproducts.net

Key Developments: Stirling Products Limited

	Stirling Products Limited (ASX:STI) Gets Approval For TB and HIV Treatment "Immunoxel" In South Africa MAY 26, 2009 11:53 - Article Views: 2,588 Australian healthcare company Stirling Products Limited (ASX:STI) is pleased to announce another milestone in the expansion of the licensed (pending joint venture approval) botanical products to markets outside of Ukraine. Immunoxel (Dzherelo) has been granted approval in South Africa. This approval will allow immediate sales of the phytoconcentrate as an immune adjuvant for TB and HIV treatment.

	Stirling Products (ASX:STI) Consolidates Licensing Deals NOV 10, 2008 13:29 - Article Views: 3,160 Stirling Products (ASX:STI) advises shareholders that it has terminated its relationship with West Australian company Cocky Smart Pty Ltd for the exclusive global licensing rights to their novel insecticide compound originally isolated from cockatoo feathers.

	Stirling Products (ASX:STI) Gets First Approval For Obesity Patent NOV 7, 2008 12:04 - Article Views: 2,149 Stirling Products (ASX:STI) advises shareholders that it has received notice that its patent application for "Methods of decreasing fat deposits and body weight in mammals and birds" has been granted in New Zealand. Patent applications have been filed in a number of different countries; this represents the first successful approval.

	Stirling Products Limited (ASX:STI) Launches Animal Product PetQuench In North America OCT 1, 2008 12:12 - Article Views: 2,034 Stirling Products (ASX:STI) advises shareholders that it launched PetQuench(tm), the first of its companion animal products, at one of Canada's largest pet shows last weekend. PetQuench(tm) was released onto the Canadian market through Stirling Animal Health at the prestigious PIJAC National Industry Trade Show in Ontario, Canada.

	Stirling Products (ASX:STI) Announces Consolidation Of Stirling North American Operation SEP 11, 2008 13:19 - Article Views: 2,690 Stirling Products (ASX:STI) advises shareholders that it has commenced a consolidation process that will result in a dedicated subsidiary for its global sales and marketing efforts. Stirling has over the last two years undergone a growth and acquisition phase with the establishment of the Danish joint venture Pulmovet in July 2006 (ASX: July 13, 2006), the acquisition of Progressive BioActives Inc.

	Stirling Products (ASX:STI) Signs First Product For Companion Animals AUG 14, 2008 13:35 - Article Views: 2,559 Stirling Products (ASX:STI) advises shareholders that it has now completed the transaction to acquire worldwide licensing rights for the product PetQuench(tm). PetQuench(tm), fortified water for dogs and cats, is already on the market in North America and is expected to be launched in Australia by the end of Q1 2009.

	Stirling Products (ASX:STI) Gets Australian Patent For Heaves In Horses JULY 28, 2008 16:57 - Article Views: 1,952 Stirling Products (ASX:STI) wishes to advise shareholders that its patent application for "the treatment of heaves in horses" with R-salbutamol has now been granted in Australia. The company previously announced that the patent had also been approved in South Africa (ASX, October 10, 2006).

	Stirling Products (ASX:STI) Announce Provale(tm) Effective At Inhibiting Loma Infection In Rainbow Trout JULY 15, 2008 12:28 - Article Views: 1,459 Stirling Products North America Inc (STI-NA)(ASX:STI) has presented results of a ground-breaking study into the Loma gill disease infection of farmed fish, especially salmon and trout, at the 2008 Annual Meeting of the American Fisheries Society (FHS-AFS). The results presented demonstrate the effectiveness of Stirling's proprietary beta glucan product, ProVale(tm), in inhibiting the impact of Loma salmonae, a costly and untreatable disease in farmed fish, especially Pacific salmon.

	Stirling Products (ASX:STI) Signs Term Sheet For Novel Insecticide JUNE 16, 2008 11:30 - Article Views: 2,396 Stirling Products (ASX:STI) advises shareholders it has signed an agreement in principle with the private Western Australian company Cocky Smart Pty Ltd for the Australian and international rights to its novel parasiticide for the prevention of flies and ticks primarily with applications in livestock.